Bottom line
DFEVX vs MEIKX: the short answer
DFEVX (Emerging Markets Value Portfolio) and MEIKX (MFS Value Fund) are both mutual funds.
But MEIKX is far broader, holding 71 positions to 1 for DFEVX, so beyond the top names it adds exposure DFEVX doesn't have.
Both charge the same expense ratio (0.44%).
Over five years, DFEVX returned +10.0% a year vs +8.3% for MEIKX (reporting dates differ).
Updated Nov 19, 2026
DFEVX vs MEIKX side by side
| DFEVX | MEIKX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Dimensional | MFS |
| Category | Emerging Markets | Large Value |
| Expense ratio | 0.44% | 0.44% |
| Annual cost per $10k | $44 | $44 |
| 10-yr cost on $10k (prospectus) | $566 | $566 |
| Max front load | — | 0% |
| 12b-1 fee | — | 0% |
| 1-yr return | +29.5% | +12.0% |
| 5-yr return (annualized) | +10.0% | +8.3% |
| 10-yr return (annualized) | +9.8% | +8.9% |
| Best quarter | +21.0% | — |
| Worst quarter | −31.9% | — |
| Net assets (fund) | $14.2B | $51.1B |
| Number of holdings | 1 | 71 |
| Portfolio turnover | 11% | 1% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
DFEVX and MEIKX share none of their top holdings.
DFEVX top 10
- Dimensional Fund Advisors — 100.03%
MEIKX top 10
- JPMorgan Chase & Co — 4.28%
- Cigna Group/The — 2.80%
- Johnson & Johnson — 2.75%
- Analog Devices Inc — 2.71%
- Morgan Stanley — 2.68%
- RTX Corp — 2.50%
- KLA Corp — 2.47%
- Progressive Corp/The — 2.45%
- Boeing Co/The — 2.42%
- Exxon Mobil Corp — 2.33%
FAQ
What is the difference between DFEVX and MEIKX?
DFEVX (Emerging Markets Value Portfolio) and MEIKX (MFS Value Fund) are both mutual funds. But MEIKX is far broader, holding 71 positions to 1 for DFEVX, so beyond the top names it adds exposure DFEVX doesn't have.
Which is cheaper, DFEVX or MEIKX?
DFEVX has the lower expense ratio (0.44%).
Should I own both DFEVX and MEIKX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.